Publications by authors named "Mario Laco"

Claim this Profile
M
Mitochondrial and redox modifications in early stages of Huntington's disease.
Carla Lopes, I Luísa Ferreira, Carina Maranga, Margarida Beatriz, Sandra I Mota

Redox Biol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically Relevant Variants Causing KCNQ1-KCNE2 Gain-of-Function Affect the Ca Sensitivity of the Channel.
Christiane K Bauer, Tess Holling, Denise Horn, Mário Nôro Laço, Ebtesam Abdalla

Int J Mol Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive Generalized Dystonia-Parkinsonism in a Child with Fumaric Aciduria.
Diogo Reis-Carneiro, Conceição Robalo, Mário Laço, Marie Vidailhet, Luísa Diogo

Mov Disord Clin Pract· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A De Novo Gene S90L Mutation in a Progressive Tetraparesis with Urinary Dysfunction and Corpus Callosum Involvement.
Joana Ramos-Lopes, Joana Ribeiro, Mário Laço, Cristina Alves, Anabela Matos

J Pediatr Genet· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A whole brain longitudinal study in the YAC128 mouse model of Huntington's disease shows distinct trajectories of neurochemical, structural connectivity and volumetric changes.
Lorena I Petrella, João M Castelhano, Mario Ribeiro, José V Sereno, Sónia I Gonçalves

Hum Mol Genet· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington's Disease Models.
Luana Naia, Tatiana R Rosenstock, Ana M Oliveira, Sofia I Oliveira-Sousa, Gladys L Caldeira

Mol Neurobiol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanded and Wild-type Ataxin-3 Modify the Redox Status of SH-SY5Y Cells Overexpressing α-Synuclein.
Carolina Noronha, Rita Perfeito, Mário Laço, Ullrich Wüllner, A Cristina Rego

Neurochem Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.
Luana Naia, I Luísa Ferreira, Teresa Cunha-Oliveira, Ana I Duarte, Márcio Ribeiro

Mol Neurobiol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington's disease carriers.
Ana C Silva, Sandra Almeida, Mário Laço, Ana I Duarte, Joana Domingues

Mitochondrion· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valosin-containing protein (VCP/p97) is an activator of wild-type ataxin-3.
Mário N Laço, Luisa Cortes, Sue M Travis, Henry L Paulson, A Cristina Rego

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compromised mitochondrial complex II in models of Machado-Joseph disease.
Mário N Laço, Catarina R Oliveira, Henry L Paulson, A Cristina Rego

Biochim Biophys Acta· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of CREB activation and histone acetylation in 3-nitropropionic acid-treated cortical neurons: prevention by BDNF and NGF.
Sandra Almeida, Teresa Cunha-Oliveira, Mário Laço, Catarina R Oliveira, A Cristina Rego

Neurotox Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BDNF regulates BIM expression levels in 3-nitropropionic acid-treated cortical neurons.
Sandra Almeida, Mário Laço, Teresa Cunha-Oliveira, Catarina R Oliveira, A Cristina Rego

Neurobiol Dis· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular turnover of the polyglutamine disease protein ataxin-3 is regulated by its catalytic activity.
Sokol V Todi, Mario N Laco, Brett J Winborn, Sue M Travis, Hsiang M Wen

J Biol Chem· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of NR1/NR2B N-methyl-D-aspartate receptors enhances heroin toxicity in HEK293 cells.
António Domingues, Teresa Cunha Oliveira, Mário L N Laço, Tice R A Macedo, Catarina R Oliveira

Ann N Y Acad Sci· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis